News & Analysis on Clinical Trial Services & Contract Research And Development
Exclusive Interview
Eli Lilly is maintaining greater in-house control as manufacturing processes become more complex, whilst MSD is leveraging external over-capacity to fulfil its needs, the firms told Outsourcing-Pharma.com during a recent visit to Ireland.
For the seventh time since 2006, law enforcement, customs, and regulatory authorities from 111 countries collaborated to identify and root out Internet-based makers and distributors of illegal drug products and medical devices.
The US FDA has issued final guidance on the transferring of clinical studies between IRBs (institutional review boards) in order to help ensure that serious disruptions in clinical trials are rare.
RNA-based drug developer Sarepta Therapeutics has agreed to acquire a manufacturing facility on 26 acres of land in Massachusetts for $25m.
Pfizer has confirmed it has dropped a £69bn ($118bn) bid to buy fellow pharma giant AstraZeneca following yesterday’s acquisition deadline.
A collaboration involving academia and industry is to develop new ways of delivering antibodies to the brain using molecular envelop technology developed by Nanomerics, a UCL spin-out company.